258 related articles for article (PubMed ID: 20864316)
21. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
Tsuboi H; Matsumoto I; Wakamatsu E; Nakamura Y; Iizuka M; Hayashi T; Goto D; Ito S; Sumida T
Clin Exp Immunol; 2010 Oct; 162(1):53-61. PubMed ID: 20731676
[TBL] [Abstract][Full Text] [Related]
22. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
Koo NY; Li J; Hwang SM; Choi SY; Lee SJ; Oh SB; Kim JS; Lee EB; Song YW; Park K
Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835
[TBL] [Abstract][Full Text] [Related]
23. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
24. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
Namkoong E; Lee SW; Kim N; Choi Y; Park K
Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies against the Second Extracellular Loop of M3R Do neither Induce nor Indicate Primary Sjögren's Syndrome.
Chen Y; Zheng J; Huang Q; Deng F; Huang R; Zhao W; Yin J; Song L; Chen J; Gao X; Liu Z; Petersen F; Yu X
PLoS One; 2016; 11(2):e0149485. PubMed ID: 26901532
[TBL] [Abstract][Full Text] [Related]
26. Systemic treatment of anti-CD4CD25 T cell monoclonal antibody exacerbates sialoadenitis in submandibular glands during the early life in lupus-prone female NZB x NZWF mice.
Hayashi T; Adachi C; Hasegawa K
J Oral Pathol Med; 2009 Feb; 38(2):234-40. PubMed ID: 19141059
[TBL] [Abstract][Full Text] [Related]
27. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies against muscarinic acetylcholine receptor M
Yu X; Riemekasten G; Petersen F
Front Biosci (Landmark Ed); 2018 Jun; 23(11):2053-2064. PubMed ID: 29772545
[TBL] [Abstract][Full Text] [Related]
29. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
30. [Immunization with 2nd extracellular loop peptide of muscarinic acetylcholine 3 receptor induces the secretion of IL-17 and IFN-γ in NOD-scid mice].
Yang L; Ju JZ; Lü FF; Zhang W; Pang CY; Wang YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1233-6. PubMed ID: 23232510
[TBL] [Abstract][Full Text] [Related]
31. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
Park K; Haberberger RV; Gordon TP; Jackson MW
Arthritis Rheum; 2011 May; 63(5):1426-34. PubMed ID: 21312189
[TBL] [Abstract][Full Text] [Related]
32. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
[TBL] [Abstract][Full Text] [Related]
33. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.
Kurien BT; Dsouza A; Igoe A; Lee YJ; Maier-Moore JS; Gordon T; Jackson M; Scofield RH
Clin Exp Immunol; 2013 Jul; 173(1):67-75. PubMed ID: 23607771
[TBL] [Abstract][Full Text] [Related]
34. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome.
Smith AJ; Jackson MW; Wang F; Cavill D; Rischmueller M; Gordon TP
Hum Immunol; 2005 Apr; 66(4):411-6. PubMed ID: 15866705
[TBL] [Abstract][Full Text] [Related]
35. M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary Sjögren's syndrome.
Abe S; Tsuboi H; Kudo H; Asashima H; Ono Y; Honda F; Takahashi H; Yagishita M; Hagiwara S; Kondo Y; Matsumoto I; Sumida T
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32614803
[TBL] [Abstract][Full Text] [Related]
36. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
37. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
38. A novel cell-based assay for inhibitory anti-muscarinic type 3 receptor antibodies in primary Sjögren's syndrome.
Bastian I; Gordon TP; Jackson MW
J Immunol Methods; 2015 Dec; 427():117-21. PubMed ID: 26584897
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
[TBL] [Abstract][Full Text] [Related]
40. A crucial role of RORγt in the development of spontaneous Sialadenitis-like Sjögren's syndrome.
Iizuka M; Tsuboi H; Matsuo N; Asashima H; Hirota T; Kondo Y; Iwakura Y; Takahashi S; Matsumoto I; Sumida T
J Immunol; 2015 Jan; 194(1):56-67. PubMed ID: 25411202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
